SUPERDRUG PARACETAMOL STOMACH SELTZER, PARACETAMOL SELTZER

Posology Do not take continuously for more than 3 days without consulting your doctor.

Adults, the elderly and children over 16 years:

Two tablets, to be dissolved in a glass of water, every 4 hours when necessary up to a maximum of 8 tablets in 24 hours.

Children aged 10 to 15 years:

One tablet every 4 to 6 hours when necessary to a maximum of four doses in 24 hours. Paediatric population Not recommended for children under 10 years of age. Method of administration For oral administration only, dissolved in water.

The information below lists reported adverse reactions, ranked using the following frequency classification: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).

Blood and lymphatic system disorders Not known: blood dyscrasias including thrombocytopenia and agranulocytosis Immune system disorders Hypersensitivity including skin rash may occur. Not known: anaphylactic shock, angioedema Skin and subcutaneous disorders Very rare cases of serious skin reactions such as Toxic Epidermal Necrolysis (TEN), Stevens-Johnson syndrome (SJS), acute generalised exanthematous pustulosis, fixed drug eruption have been reported.

Absorption of neutralised sodium bicarbonate can cause alkalosis - this is usually transient and clinically insignificant in people with normal renal function. The release of carbon dioxide from bicarbonate containing antacids can cause belching, occasional nausea, abdominal distension and flatulence.

Metabolism and nutrition disorders Not known: high anion gap metabolic acidosis. 4). Pyroglutamic acidosis may occur as a consequence of low glutathione levels in these patients. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Care is advised in the administration of paracetamol to patients with severe renal or severe hepatic impairment. The hazard of overdose is greater in those with non- cirrhotic alcoholic liver disease. g. chronic alcoholism) who were treated with paracetamol at therapeutic dose for a prolonged period or a combination of paracetamol and flucloxacillin.

If HAGMA due to pyroglutamic acidosis is suspected, prompt discontinuation of paracetamol and close monitoring is recommended. The measurement of urinary 5-oxoproline may be useful to identify pyroglutamic acidosis as underlying cause of HAGMA in patients with multiple risk factors.

Do not exceed the recommended dose as excessive or prolonged use may lead to alkalosis. Do not take with any other paracetamol-containing products. If your symptoms persist for more than three days or worsen at any time, you should see your doctor.

Keep all medicines out of the reach and sight of children. Immediate medical advice should be sought in the event of an overdose, even if you feel well, because of the risk of delayed, serious liver damage. This medicinal product contains sodium and sorbitol.

4 % of the WHO recommended maximum daily intake of 2 g sodium for an adult.

Sorbitol:

This medicine contains 50mg sorbitol in each effervescent tablet. Patients with rare hereditary fructose intolerance (HFI)_ should not take/be given this medicinal product.

1.